Brief: Avacta Therapeutics' AVA6000 Phase 1a Dose Escalation Shows Early Efficacy
07/03/2025 09:40
March 7 (Reuters) - Avacta Group PLC AVCT.L: AVACTA THERAPEUTICS - PROMISING EARLY EFFICACY, SAFETY DATA FOR AVA6000 IN PHASE 1A DOSE ESCALATION, ONGOING ENROLLMENT IN PHASE 1B EXPANSION COHORT Source text: ID:nRSG8110Za Further company coverage: AVCT.L ((Reuters.Briefs@thomsonreuters.com;))